Evidence map›Paper›PMID 17251302›Full record

ArticleJournal of virology2007

The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo.

Xibing Che, Barbara Berarducci, Marvin Sommer, William T Ruyechan, Ann M Arvin

Abstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.Current topics in microbiology and immunology · 2010
    Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xibing CheDepartment of Pediatrics, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305-5208, USA. xibing@stanford.edu
Barbara Berarducci
Marvin Sommer
William T Ruyechan
Ann M Arvin
Stanford University · USUniversity at Buffalo, State University of New York · US

Funding

Varicella-zoster Virus: Tegument Proteins in PathogenesisR01AI053846 · NIAID · STANFORD UNIVERSITY · PI ARVIN, ANN · 2003 to 2012
$4.1M
Structure/Function of Varicella Zoster Virus DNAR01AI018449 · NIAID · U.S. UNIFORMED SERVICES UNIV OF HLTH SCI · PI RUYECHAN, WILLIAM T · 1985 to 2007
$1.8M
Structure/Function of Varicella Zoster Virus DNA.R56AI018449 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI HAY, JOHN I. · 2008 to 2009
$788k
Structure/Function of Varicella Zoster Virus DNAR21AI018449 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI RUYECHAN, WILLIAM T · 2002 to 2002
$304k
NIAID NIH HHS AI 18449NIAID NIH HHS AI 53846NIAID NIH HHS R01 AI018449NIAID NIH HHS R01 AI053846NIAID NIH HHS R21 AI018449NIAID NIH HHS R56 AI018449
6 · The paper itself

Abstract

Varicella-zoster virus (VZV) open reading frame 10 (ORF10) is a determinant of virulence in SCIDhu skin xenografts but not in human T cells in vivo. In this analysis of the regulation of ORF10 transcription, we have identified four ORF10-related transcripts, including a major 1.3-kb RNA spanning ORF10 only and three other read-through transcripts. Rapid-amplification-of-cDNA-ends experiments indicated that the 1.3-kb transcript of ORF10 has single initiation and termination sites. In transient expression assays, the ORF10 promoter was strongly stimulated by the major VZV transactivator, IE62. Deletion analyses revealed approximate boundaries for the full ORF10 promoter activity between -75 and -45 and between +5 and -8, relative to the ORF10 transcription start site. The recombinant virus POKA10-Deltapro, with the ORF10 promoter deletion, blocked transcription of ORF10 and also of ORF9A and ORF9 mRNAs, whereas expression of read-through ORF9A/9/10 and ORF9/10 transcripts was increased, compensating for the loss of the monocistronic mRNAs. The cellular factor USF bound specifically to its consensus site within the ORF10 promoter and was required for IE62 transactivation, whereas disrupting the predicted TATA boxes or Oct-1 binding elements had no effect. The USF binding site was disrupted in the recombinant virus, POKA10-proDeltaUSF, and no ORF10 protein was produced. Both ORF10 promoter mutants reduced VZV replication in SCIDhu skin xenografts. These observations provided further evidence of the contribution of the ORF10 protein to VZV pathogenesis in skin and demonstrated that VZV depends upon the cellular transcriptional factor USF to support its virulence in human skin in vivo.

Indexed as

AnimalsCell LineGene Expression Regulation, ViralGenes, ReporterHerpesvirus 3, HumanHumansMiceMice, SCIDMutationOpen Reading FramesPromoter Regions, GeneticResponse ElementsRNASkin TransplantationTrans-ActivatorsTranscription, GeneticRNATrans-ActivatorsUpstream Stimulatory Factors

Identifiers

PMID17251302
PMCPMC1866059
OpenAlexW2130780690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.